Kanthida Kusonmano


Academic Position : Lecturer

Tel. : (+66)2-470-7579

Email : kanthida.kus@kmutt.ac.th

Website : Link

Research Interests

  • Bioinformatics
  • High-throughput and High-dimensional Data Analysis
    • Metagenomic Data Analysis (Main focus)
    • Next-generation and Third-generation Sequencing Data Analysis for Genomics
    • Microarray or Gene Expression Data Analysis
  • Biomarkers Identification
  • Data Mining, Supervised and Unsupervised Machine Learning

Education

Dr.rer.nat. in Bioinformatics

Recent Publications

  1. Kusonmano, K. ; Holst, F. ; Werner, HMJ. ; Mjos, S. ; Hoivik, E.A. ; Wik, E. ; Berg, A. ; Birkeland, E. ; Gibson, W.J. ; Halle, M.K. ; Trovik, J. ; Cherniack, A.D. ; Kalland, K.H. ; Mills, G.B. ; Singer, C.F. ; Krakstad, C. ; Beroukhim, R. ; Salvesen, H.B., A 2019 “PIK3CA Amplification Associates with Aggressive Phenotype but Not Markers of AKT-MTOR Signaling in Endometrial Carcinoma” CLINICAL CANCER RESEARCH Volume: 25 , Issue: 1 , Pages: 334-345
  2. Kusonmano, KHalle, MK ; Wik, E ; Hoivik, EA ; Krakstad, C ,; Mauland, KK ; Tangen, IL ; Berg, A ; Werner, HMJTrovik, J ; Oyan, AM ; Kalland, KHJonassen, I ; Salvesen, HB ; Petersen, K 2018 “Identification of highly connected and differentially expressed gene subnetworks in metastasizing endometrial cancer” PLOS ONE Volume: 13 Issue: 11
  3. Halle, MKTangen, IL ; Berg, HF ; Hoivik, EA ; Mauland, KK ; Kusonmano, K ; Berg, A ; Hurtado, A ; Kalland, KH ; Oyan, AM  ; Stefansson, I ; Vintermyr, OK  ; Werner, HM  ; Haldorsen, IS ; Trovik, J ; Salvesen, HB ; Krakstad, C 2018 “HER2 expression patterns in paired primary and metastatic endometrial cancer lesions” BRITISH JOURNAL OF CANCER Volume: 118 Pages: 378-387
  4. Mauland, K K; Wik, E; Hoivik, EA.; Kusonmano, KHalle, MK ; Berg, A ; Haugland, HK ; Oyan, AM ; Kalland, KH ; Stefansson, IM ; Akslen, LA ; Krakstad, C ; Trovik, J  ; Werner, HMJ  ; Salvesen, HB 2017 “Aneuploidy related transcriptional changes in endometrial cancer link low expression of chromosome 15q genes to poor survival” ONCOTARGET Volume: 8 Issue: 6   Pages: 9696-9707
  5. Mjos, SWerner, HMJ ; Birkeland, E ; Holst, F  ; Berg, A ; Halle, MK ; Tangen, IL  ; Kusonmano, K  ; Mauland, KK ; Oyan, AM ; Kalland, KH  ; Lewis, AE  ; Mills, GB  ; Krakstad, C  ; Trovik, J ; Salvesen, HB ; Hoivik, EA 2017 “PIK3CA exon9 mutations associate with reduced survival, and are highly concordant between matching primary tumors and metastases in endometrial cancer” SCIENTIFIC REPORTS   Volume: 7     Article Number: 10240
  6. Halle, MKOjesina, AI  ; Engerud, HWoie, K  ; Tangen, IL  ; Holst, F ; Hoivik, E ; Kusonmano, K Haldorsen, IS ; Vintermyr, OK ; Trovik, J ; Bertelsen, BI ; Salvesen, HB ; Krakstad, C 2017 “Clinicopathologic and molecular markers in cervical carcinoma: a prospective cohort study ” AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY Volume: 217 Issue: 4 Article Number: 432.e1-17
  7. Gibson, WJHoivik, EA ; Halle, MK ; Taylor-Weiner, A ; Cherniack, AD  ; Berg, A ; Holst, F ; Zack, TI ; Werner, HMJ ; Staby, KM ; Rosenberg, M ; Stefansson, IM  ; Kusonmano, K ; Chevalier, A ; Mauland, KK ; Trovik, J ; Krakstad, C ; Giannakis, M  ; Hodis, E ; Woie, K ; Bjorge, L ; Vintermyr, OK ; Wala, JA ; Lawrence, MS ; Getz, G  ; Carter, SL  ; Beroukhim, R ; Salvesen, HB 2016 “The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis”  NATURE GENETICS   Volume: 48   Issue: 8   Pages: 848
  8. Krakstad C., Tangen I.L., Hoivik E.A., Halle M.K., Berg A., Werner H.M., Ræder M.B., Kusonmano K, Zou J.X., Øyan A.M., Stefansson I., Trovik J., Kalland K.H., Chen H.W., Salvesen H.B. ATAD2 overexpression links to enrichment of B-MYB-translational signatures and development of aggressive endometrial carcinoma. Oncotarget. 2015;6(29):28440-52.
  9. Stefansson I.M., Raeder M., Wik E., Mannelqvist M., Kusonmano K., Knutsvik G., Haldorsen I., Trovik J., Øyan A.M., Kalland K.H., Staff A.C., Salvesen H.B., Akslen L.A. Increased angiogenesis is associated with a 32-gene expression signature and 6p21 amplification in aggressive endometrial cancer. Oncotarget. 2015; 6(12):10634-45.
  10. Berg A., Hoivik E.A., Mjøs S., Holst F., Werner H.M., Tangen I.L., Taylor-Weiner A., Gibson W.J., Kusonmano K., Wik E., Trovik J., Halle M.K., Oyan A.M., Kalland K.H., Cherniack A.D., Beroukhim R., Stefansson I., Mills G.B., Krakstad C. and Salvesen H.B. Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients. Oncotarget. 2015;6(2):1327-39.